379 related articles for article (PubMed ID: 10102963)
1. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.
Xiao SD; Liu WZ; Hu PJ; Xia DH; Tytgat GN
Aliment Pharmacol Ther; 1999 Mar; 13(3):311-5. PubMed ID: 10102963
[TBL] [Abstract][Full Text] [Related]
2. Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.
Liu WZ; Xiao SD; Shi Y; Wu SM; Zhang DZ; Xu WW; Tytgat GN
Aliment Pharmacol Ther; 1999 Mar; 13(3):317-22. PubMed ID: 10102964
[TBL] [Abstract][Full Text] [Related]
3. A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidine.
Liu WZ; Xiao SD; Hu PJ; Lu H; Cui Y; Tytgat GN
Aliment Pharmacol Ther; 2000 Nov; 14(11):1519-22. PubMed ID: 11069324
[TBL] [Abstract][Full Text] [Related]
4. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Fakheri H; Malekzadeh R; Merat S; Khatibian M; Fazel A; Alizadeh BZ; Massarrat S
Aliment Pharmacol Ther; 2001 Mar; 15(3):411-6. PubMed ID: 11207517
[TBL] [Abstract][Full Text] [Related]
5. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
[TBL] [Abstract][Full Text] [Related]
6. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
[TBL] [Abstract][Full Text] [Related]
7. A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate.
Weldon MJ; Broadbent A; Chambers S; Mistry R; Ranganath L; Gould SR
Aliment Pharmacol Ther; 1996 Jun; 10(3):279-83. PubMed ID: 8791951
[TBL] [Abstract][Full Text] [Related]
8. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU
Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520
[TBL] [Abstract][Full Text] [Related]
10. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
[TBL] [Abstract][Full Text] [Related]
11. Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
Gschwantler M; Dragosics B; Schütze K; Wurzer H; Hirschl AM; Pasching E; Wimmer M; Klimpfinger M; Oberhuber G; Brandstätter G; Hentschel E; Weiss W
Aliment Pharmacol Ther; 1999 Aug; 13(8):1063-9. PubMed ID: 10468682
[TBL] [Abstract][Full Text] [Related]
12. Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
Isakov V; Domareva I; Koudryavtseva L; Maev I; Ganskaya Z
Aliment Pharmacol Ther; 2002 Jul; 16(7):1277-82. PubMed ID: 12144577
[TBL] [Abstract][Full Text] [Related]
13. Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options.
Sanches B; Coelho L; Moretzsohn L; Vieira G
Helicobacter; 2008 Dec; 13(6):572-6. PubMed ID: 19166424
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Zheng Q; Pan Y; Zhang L; Xiao SD
Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
[TBL] [Abstract][Full Text] [Related]
16. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
17. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
Catalano F; Branciforte G; Catanzaro R; Cipolla R; Bentivegna C; Brogna A
Aliment Pharmacol Ther; 2000 Oct; 14(10):1329-34. PubMed ID: 11012478
[TBL] [Abstract][Full Text] [Related]
19. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
[TBL] [Abstract][Full Text] [Related]
20. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
Cammarota G; Cannizzaro O; Tursi A; Papa A; Gasbarrini A; Cuoco L; Cianei R; Armuzzi A; Fedeli P; Fedeli G; Gasbarrini G
Aliment Pharmacol Ther; 1998 Jun; 12(6):539-43. PubMed ID: 9678813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
